Â鶹´«Ã½

Three panel discussions followed by a networking reception featuring leading investors, financing experts, biotech executives and business development leaders discussing growth of Biotech companies beyond traditional equity financing.

Programme: 

Panel 1: Alternative Financing & Venture Debt for Life Science - How venture debt, royalty financing and other non-dilutive solutions are reshaping life science financing

• Antoine de Lachaux – Head of Life Sciences & Health, European Investment Bank (EIB)
• Sonia Benhamida – Managing Director, BlackRock
• Guus de Haan – Executive Director, Life Sciences, Van Lanschot Kempen
• Anders Hagstrøm – Partner, Bech-Bruun
• Thomas Holm Pedersen – Chief Executive Officer, NMD Pharma

Panel 2: Building and Financing Life Science in Denmark - How investors, institutions and ecosystem partners help companies scale from startup to global impact

• Christian E. Elling – Managing Partner & SVP, Â鶹´«Ã½ BioCapital
• Søren Møller – Managing Partner, Seed Investments, Novo Holdings
• Mads Lacoppidan – Investment Director, EIFO
• Trine Bartholdy – Chief Business Officer, BioInnovation Institute (BII)
• Claus Andersson – Managing Partner, Sunstone Life Science Ventures
• Ari-Pekka Laitsaari - Senior Advisor, European Investment Bank (EIB)

Panel 3: Business Development & Strategic Partnerships - How licensing, collaborations and M&A drive growth and strategic value

• Niels Vrang – Board Member and Co-Founder, Gubra
• Henriette Wennicke – Chief Financial Officer, Zealand Pharma
• Eric Stewart – Managing Director, Leerink Partners
• Maria Alfaiate – EVP, Corporate, Portfolio & Product Strategy, H. Lundbeck A/S